Market Overview

The Global Contrast Media Market was valued at USD 6,137.1 million in 2023 and is expected to reach USD 11,027.2 million by 2031 while growing at a CAGR of 7.6% during the forecast period (2024-2031). 

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global contrast media market growth.

Furthermore, the global contrast media industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Type Analysis

The Global Contrast Media Market is segmented among Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, and Barium-based Contrast Media, based on Type. In 2023, Iodinated Contrast Media accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Procedure Analysis

The Global Contrast Media Market is segmented among X-ray/Computed Tomography, Magnetic Resonance Imaging, and Ultrasound, based on Procedure. In 2023, X-ray/Computed Tomography accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Contrast Media Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Bayer AG, Bracco Diagnostic Inc., GE Healthcare, Guerbet Group, Lantheus Medical Imaging Inc., Spago Nanomedical AB, FUJIFILM Corporation, Beijing Beilu Pharmaceutical Co. Ltd, and Taejoon Pharm.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Contrast Media Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Contrast Media Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Contrast Media Market Segmentation, By Type

• Global Contrast Media Market Share Analysis, By Type

• Global Contrast Media Market Growth Analysis, By Type

• Global Contrast Media Market Trends, By Type

  • Iodinated Contrast Media

  • Gadolinium-based Contrast Media

  • Microbubble Contrast Media

  • Barium-based Contrast Media

6. Global Contrast Media Market Segmentation, By Procedure

• Global Contrast Media Market Share Analysis, By Procedure

• Global Contrast Media Market Growth Analysis, By Procedure

• Global Contrast Media Market Trends, By Procedure

  • X-ray/Computed Tomography

  • Magnetic Resonance Imaging

  • Ultrasound

7. Global Contrast Media Market Segmentation, By Indication

• Global Contrast Media Market Share Analysis, By Indication

• Global Contrast Media Market Growth Analysis, By Indication

• Global Contrast Media Market Trends, By Indication

  • Cardiovascular Disease

  • Oncology

  • Gastrointestinal Disorders

  • Neurological Disorders

  • Other Indications

• 8. Global Contrast Media Market Segmentation, By Region

• Global Contrast Media Market Share Analysis, By Region

• Global Contrast Media Market Growth Analysis, By Region

• Global Contrast Media Market Trends, By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East

  • Africa

9. Competitive Landscape

• Bayer AG*

  • Company Overview

  • Financial Performance

  • Key Development/Strategies

  • SWOT Analysis

• Bracco Diagnostic Inc.

• GE Healthcare

• Guerbet Group

• Lantheus Medical Imaging Inc.

• Spago Nanomedical AB

• FUJIFILM Corporation

• Beijing Beilu Pharmaceutical Co. Ltd

• Taejoon Pharm

 *Similar analysis will be provided for each company listed above.